Logo of Dallah Healthcare
Dallah Healthcare Co.’s shareholders approved authorizing the board of directors to pay interim dividend for 2021 on a quarterly or semi-annual basis, during the ordinary general meeting (OGM) held on May 24, 2021.
The company said in a bourse statement that shareholders approved the transactions and contracts concluded between the company and Tarek bin Othman Al-Qasabi, worth SAR 668,382, as he has direct interest presented in contract of administrative consultations, without any preferential conditions.
Shareholders also approved the board and audit reports, as well as audited financial statements for 2020, in addition to releasing the board members from liabilities for the same year.
Meanwhile, they approved all other items on the meeting’s agenda including a board remuneration of SAR 1.8 million for 2020.
Comments
{{DisplayName}}
{{ElapsedTime}}